Skip to content

Study · Case report or series · n = 1 · 2024

2 results

A diabetic patient increased premature ventricular contractions after using liraglutide: a case report.

Huang L, Yu H, Fang Y

Frontiers in cardiovascular medicine31 Jan 2024Cited by 1 (Europe PMC)

PMID38357515 (opens in a new tab)PMCIDPMC10865887 (opens in a new tab)DOI10.3389/fcvm.2024.1332754 (opens in a new tab)PepBankPUB-38357515
Download PDFPubMedAsk about this study
Jump to 2 results

Summary

The common adverse reactions of liraglutide are hypoglycemia and gastrointestinal reactions. This case reports a patient with type 2 diabetes mellitus who had an increase in ventricular premature beats after using liraglutide and a decrease in ventricular premature beats after stopping liraglutide, suggesting that clinicians should rule out the possibility of drug-related adverse reactions when using liraglutide in the treatment of diabetes mellitus complicated with coronary heart disease and arrhythmia.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesSafety outcome

    In a patient with type 2 diabetes, ventricular premature beats increased after liraglutide was used.

    In plain wordsIn one patient with type 2 diabetes, extra heartbeats from the lower heart chambers increased after liraglutide was used.

    Peptide
    Liraglutide
    Outcome
    IncreaseVentricular premature beats after starting liraglutide
    Study

    n = 1

    Outcome group
    Adverse events · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    This case reports a patient with type 2 diabetes mellitus who had an increase in ventricular premature beats after using liraglutide
  2. 02HumanCase report or seriesSafety outcome

    In a patient with type 2 diabetes, ventricular premature beats decreased after liraglutide was stopped.

    In plain wordsIn one patient with type 2 diabetes, extra heartbeats from the lower heart chambers decreased after liraglutide was stopped.

    Peptide
    Liraglutide
    Outcome
    DecreaseVentricular premature beats after stopping liraglutide
    Study

    n = 1

    Outcome group
    Adverse events · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    a decrease in ventricular premature beats after stopping liraglutide
    1 context sentence
    Summary · context
    This case reports a patient with type 2 diabetes mellitus who had an increase in ventricular premature beats after using liraglutide

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.